February 2018

Shri J P Nadda launches Viral Load test for People Living with HIV/AIDS (PLHIV)

  • Posted on: 27 February 2018
  • By: Shalini.Sharma

Shri J P Nadda, Union Minister of Health and Family Welfare launched the ‘‘Viral Load testing for all People Living with HIV/AIDS (PLHIV),”at a function.
The initiative will provide free of cost viral load testing for 12 lakh PLHIV on treatment in the country at least once a year. Shri Nadda further announced that after ‘Treat All’, Viral Load test is a big step forward in treating and monitoring people living with HIV. “This Viral Load test is of immense importance to monitor the effectiveness of treatment of patients taking lifelong Antiretroviral Therapy,” he said.
Smt. Anupriya Patel, Minister of State for Health & Family Welfare was also present at the launch function.

Merck to acquire Viralytics for expanding in Immuno Oncology business

  • Posted on: 27 February 2018
  • By: PharmaTutor News

MSD and Viralytics Limited  announced that the companies have signed a definitive agreement under which it is proposed that Merck, through a subsidiary, will acquire Viralytics, an Australian publicly traded company focused on oncolytic immunotherapy treatments for a range of cancers by way of a scheme of arrangement (Scheme) for AUD 1.75 cash per Viralytics share. The proposed acquisition values the total issued shares in Viralytics at approximately AUD 502 million (USD 394 million). The cash consideration of AUD 1.75 per share represents a premium of 160% to the one month volume weighted average price (VWAP) of Viralytics shares.

EMA committee support more ethical use of animals in medicine testing

  • Posted on: 27 February 2018
  • By: Shalini.Sharma

The European Medicines Agency (EMA) has published that the Committee for Medicinal Products for Human Use (CHMP) and the Committee for Medicinal Products for Veterinary Use (CVMP) – to support the implementation of the so-called 3Rs principles for more ethical use of animals in medicine testing across the European Union (EU).

Amglidia: First medicine to treat neonatal diabetes

  • Posted on: 27 February 2018
  • By: Shalini.Sharma

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended granting a marketing authorisation in the European Union (EU) for Amglidia (glibenclamide), a medicine indicated for the treatment of neonatal diabetes mellitus (NDM), for use in newborns, infants and children.

Opening for freshers as Research Scholars at NAIB- under Government of India

NIAB is an autonomous and premier institute of the Department of Biotechnology (DBT), Government of India. The Institute wishes to develop and harness novel and emerging biotechnological tools and applications, and take up research in cutting-edge areas for improving animal health and productivity as well as contribute to human health and welfare.

Post : Research Scholars Program

Recruitment for B.Pharm/MBA as Manager at HLL Lifecare Limited - Ministry of Health & Family Welfare | 07 posts

HLL Lifecare Limited, a Mini Ratna Central Public Sector Enterprise under the Ministry of Health & Family Welfare, Govt. of India is a global provider of high quality healthcare products & services. With state-of-the-art manufacturing facilities spanning across India, HLL is diversifying into vaccine manufacturing, lifecare services, sanitary napkins besides engaging in procurement consultancy, healthcare infrastructure development and facility management.


Opportunity for Pharmaceutical professionals for the post of Research Associate at CSIR-URDIP

CSIR-URDIP works in the area of Scientific Informatics (ChemBioinformatics / Patent Informatics / Phytoinformatics / Toxinformatics) and related software development projects. We believe in delivering outstanding knowledge-based services and solutions with high quality and unmatched standards.  CSIR-URDIP has a vibrant scientific community consisting of Scientists, Intellectual Property Specialists, Technologists and Project Assistants. The scientific staff are the true strength of CSIR-URDIP. Scientists and Technologists are permanent employees while Project Assistants are hired for a fixed duration depending upon the needs of a particular project. We have an open work culture where talents are honed, achievements recognized, and every contribution is valued.. Hierarchy matters very little when it comes to working relationships at CSIR-URDIP. Senior colleagues provide a nurturing environment and actively mentor freshly recruited scientists and project staff.

CSIR has set up a Unit for Research and Development of Information Products (CSIR-URDIP) at Pune to work in the area of Scientific Informatics relating to Chembioinformatics / Patent Informatics / Phytoinformatics and Toxinformatics.

Post : Research Associate – II / III (Chemical or Pharmaceutical Sciences)